View in EDS HTML Full Text PDF Full Text

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].

Saved in:
Bibliographic Details
Title: The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].
Authors: Clarke, Stephen John1 (AUTHOR) stephen.clarke@sydney.edu.au, Burge, Matthew2 (AUTHOR), Feeney, Kynan3 (AUTHOR), Gibbs, Peter4 (AUTHOR), Jones, Kristian5 (AUTHOR), Marx, Gavin6 (AUTHOR), Molloy, Mark P.7 (AUTHOR), Price, Timothy8 (AUTHOR), Reece, William H. H.9 (AUTHOR), Segelov, Eva10 (AUTHOR), Tebbutt, Niall C.11 (AUTHOR)
Source: PLoS ONE. 3/6/2020, Vol. 15 Issue 3, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0229900